{"schema_version":"1","generated_at":"2026-11-04T23:05:05.052Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shelonitda-rose","json_url":"https://www.findmykol.com/kol/shelonitda-rose/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shelonitda-rose","name":"Shelonitda Rose","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Bristol-Myers Squibb","institution_url":"https://www.findmykol.com/institution/bristol-myers-squibb","city":"New Brunswick","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1588736631","openalex":"A5112451928"},"summary":"Shelonitda Rose is a Hematology physician affiliated with Bristol-Myers Squibb. OpenAlex indexes 81 publications with 2,805 citations (h-index 20).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":81,"cited_by_count":2805,"h_index":20,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2024,"amount_usd":18.97,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588736631"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1588736631","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Overall survival (OS) and duration of response for transfusion independence (TI) in erythropoiesis stimulating agent (ESA)–naive patients (pts) with very low-, low-, or intermediate-risk myelodysplastic syndromes (MDS) treated with luspatercept (LUSPA) vs epoetin alfa (EA) in the COMMANDS trial.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.6512","status":"verified"},{"title":"Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial","year":2025,"journal":"Advances in Therapy","source_url":"https://doi.org/10.1007/s12325-025-03208-5","status":"verified"},{"title":"Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab","year":2025,"journal":"Therapeutic Advances in Hematology","source_url":"https://doi.org/10.1177/20406207251347344","status":"verified"},{"title":"Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial","year":2024,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(24)00203-5","status":"verified"},{"title":"Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis","year":2024,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024012939","status":"verified"}],"source":"works"},"contact":{"address_1":"125 PATERSON ST","address_2":"CLINICAL ACADEMIC BUILDING - SUITE 5200","city":"New Brunswick","state":"NJ","zip":"089011962","phone":"732-235-7223","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1588736631","source":"identity"},"similar":[{"name":"Yixin Li","slug":"yixin-li","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/yixin-li","json_url":"https://www.findmykol.com/kol/yixin-li/profile.json"},{"name":"Alan J. Korman","slug":"alan-korman","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/alan-korman","json_url":"https://www.findmykol.com/kol/alan-korman/profile.json"},{"name":"Robert Plenge","slug":"robert-plenge","institution":"Bristol-Myers Squibb","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/robert-plenge","json_url":"https://www.findmykol.com/kol/robert-plenge/profile.json"},{"name":"Ray Hershberger","slug":"ray-hershberger","institution":"Bristol-Myers Squibb","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/ray-hershberger","json_url":"https://www.findmykol.com/kol/ray-hershberger/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2008-02-06","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}